Simcha Therapeutics

  • About
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • Pipeline
  • Patients
  • Culture & Careers
  • News
    • Press Releases
    • Media
    • Publications
  • Contact

Going after an old GSK target in a new way, a Yale spinout hits the clinic and nabs a modest raise

Engineering a better immunotherapy to outwit cancer — and launch a biotech

Simcha debuts with $25M to advance custom-built IL-18 for cancer

Simcha Therapeutics logo

© 2023 Simcha Therapeutics

Explore

  • About
  • Science
  • Patients
  • Culture & Careers
  • News
  • Contact

Follow

Legal

  • Privacy Policy
MENU
  • About
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • Pipeline
  • Patients
  • Culture & Careers
  • News
    • Press Releases
    • Media
    • Publications
  • Contact